Page 264 - ASHG 2013 Program Guide

POSTER SESSIONS
  251
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
3375
W Drug-sensitivity assay for sequence variants
verification
K. Tao, S. Tavtigian.
3376
T SNP variation in microRNAs targeting the
tumor suppressor gene
PTEN
.
V. A. Ware, A. Jones, C.
LaViolette, C. Corcoran, A. Maletz, J. A. Wilder.
3377
F Missense mutation of the last nucleotide of
exon 1,
CDH1 c.48 G
.
C
(
Q16H
),
contributes to cancer
predisposition through disruption of normal splicing
and generation of missense mutation.
L. Zhang, A. Xiao,
J. Ruggeri, R. Bacares, S. Melo, J. Figueiredo, J. Simões-
Correia, R. Seruca, M. Shah.
3378
W The K-type human endogenous retroviral
element encodes fusogenic activity in melanoma cells.
J. Dong, G. Huang, Z. Li, X. Wan, Y. Wang.
3379
T Detection of P16, cyclin D1 and Bcl-2 expression
in pancreatic neoplasms.
S. Lai, X. Zhou.
3380
F Exome-based method to determine cancer
tissue of origin.
K. Robasky, E. Aronesty, W. D. Jones.
3381
W A novel statistic method for drug response
prediction with big RNA-seq data.
M. Xiong, L. Ma, M.
Chen, S. Guo.
3382
T Leukemia relapse in donor cells ten years after
allogeneic hematopoietic stem cell transplantation
for acute myeloid leukemia.
G. Calabrese, L. Militti, R.
DiGianfilippo, M. Alfonsi, P. Guanciali-Franchi, D. Fantasia,
P. Bavaro, P. DiBartolomeo, G. Palka.
3383
F Photodynamic therapy effect in EGF pathway
gene expression in glioblastoma as a biological model.
L. B. de Paula, F. L. Primo, N. T. A. Peres, N. M. Martinez-
Rossi, A. Rossi, A. C. Tedesco, Supported by CNPQ,
FAPESP, FAEPA.
3384
W Elevated expression of maspin mRNA as a
predictor of survival for stage II gallbladder cancer.
K.
Baghel, H. R. Kazmi, S. Raj, A. Chandra, R. N. Srivastava.
3385
T Prognostic signature in papillary thyroid
carcinoma patients that undergone total thyroid
ablation.
M. C. Barros Filho, F. A. Marchi, C. A. Pinto, S.
R. Rogatto, L. P. Kowalski.
3386
F LOX-1, a novel metabolic target in human breast
and colon cancer.
M. Biancolella, M. J. Zonetti, T. Fisco,
P. Mazzarelli, F. Sangiuolo, L. Saieva, M. Murdocca, G.
Novelli, S. Pucci.
3387
W Increased frequencies of
GSTM1
and
GSTT1
null genotypes in Indian patients with leukemia.
S.
Caplash, S. Kaur, R. Arora.
3388
T Two different
BRCA2
mutations found in a
multigenerational family with a history of breast,
prostate, and lung cancers.
D. Caporale, E. Swenson.
3363
W Integrative analysis of acute myeloid leukemia
with genetic, epigenetic, and transcriptional data.
S.
Li, F. Garrett-Bakelman, J. Patel, T. Hricik, M. Guzman, M.
Carroll, A. Brown, R. D’Andrea, R. Levine, A. Melnick, C.
Mason.
3364
T Tissue-of-origin chromatin organization shapes
the mutational landscape of cancer.
P. Polak, R. Karlic,
A. Koren, B. Thurman, R. Sandstrom, A. Reynolds, E.
Rynes, J. Stamatoyannopoulos, S. Sunyaev.
3365
F Association of eNOS 4 a/b polymorphism in
Mexican patients with breast cancer.
R. Ramírez, M. P.
Gallegos, A. Ramos, L. Gómez’Flores, D. Carrillo, O. Soto,
I. Gutíerrez, I. Delgado, A. M. Puebla, L. E. Figuera, R. P.
Mariaud, G. M. Zúñiga.
3366
W Analysis of methylation pattern of candidates
genes regulated by TDG in patients with germline
mutations in
TP53
gene.
F. Fortes, H. Kuasne, F. Marchi,
S. Rogatto, M. Achatz.
3367
T Functional characterization of mutations in the
spliceosomal component SF3B1 in uveal melanoma.
A. Bowcock, M. Sentmanat, H. N. Anbunathan, E. D. O.
Roberson, J. W. Harbour.
3368
F Role of rs9620497 with
CRYBB2
expression
levels in African American women with invasive breast
cancer.
S. M. Brown, C. D. Shriver, R. E. Ellsworth.
3369
W Functional characterization of melanoma-
associated common variants in
PARP1
.
J. Choi, M.
M. Makowski, W. J. Kim, T. Zhang, M. H. Law, M. Xu, M.
Kovacs, H. Parikh, L. G. Aoude, M. Gartside, H. H. Yin, J.
M. Trent, S. Macgregor, N. K. Hayward, K. M. Brown.
3370
T Genetic polymorphisms in DNA base excision
repair gene
XRCC1
and the risk of head and neck
cancer.
K. Chukka, Z. Vishnuvardhan, U. Radhakrishna.
3371
F Characterization of immunogenetics variants
of the
CCR2
,
CCR5
,
and
HLA-G
genes as potential
targets for diagnosis, prognosis and treatment in
women with sporadic and familial breast cancer.
C. de
Oliveira Giongo, A. P. Carneiro Brandalize, P. Ashton Prolla,
J. A. Bogo Chies.
3372
W A common germline deletion of
APOBEC3B
alters the somatic mutation profile in b east cancer.
R.
J. Delahanty, Y. Zhang, Y. Guo, Y. Shyr, W. Zheng, J. Long.
3373
T Functional variants at the 5q11 breast cancer
risk locus regulate
MAP3K1
expression through long-
range regulatory elements.
S. L. Edwards, D. M. Glubb,
M. J. Maranian, K. B. Meyer, K. A. Pooley, K. Michailidou,
K. M. Hillman, S. Kaufmann, G. Chenevix-Trench, D.
F. Easton, J. D. French, A. M. Dunning, Breast Cancer
Association Consortium.
3374
F Transcriptional regulation and prostate cancer
risk loci.
R. J. Klein, J. Hayes, X. Xu, J. Farber, R.-M.
Väänänen, P. Taimen, J. Vijai, H. Lilja, K. Pettersson, K. Offit.